Return to homepagePandemic Pact

Seroprevalence of SARS-CoV-2 antibodies and herd immunity in the Swiss population - A nationwide study

  • Funded by Federal Office of Public Health (FOPH)
  • Total publications:4 publications

Grant number: 47149

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $3,067,698

  • Funder

    Federal Office of Public Health (FOPH)

  • Principal Investigator

    Abteilung Übertragbare Krankheiten Sekretariat der

  • Research Location

    Switzerland

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This study aims to determine the extent of SARS-CoV-2 spread within the Swiss population. To this end, the prevalence of past infections and the proportion of the general population with immunity to SARS-CoV-2 will be examined nationwide in order to estimate the degree of herd immunity. This information is necessary to define appropriate measures for managing the coronavirus epidemic in the future. This information is also important for developing future vaccination strategies once a vaccine becomes available.

4 Publications linked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Automated nucleotide sequencing reveals substantial disparity between the HLA-A2 genes of bone marrow transplant recipients and donors.

Nucleotide sequence of HLA-B*5505, which expresses a unique HLA class I polymorphism.

Corrected nucleotide sequences for HLA-A*2901 and HLA-A*3301.

Nucleotide sequence for HLA-A*0221 which encodes a novel HLA class I polymorphic residue.